NeuPath Health Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported revenue was CAD 66.1 million compared to CAD 62.65 million a year ago. Net loss was CAD 0.107 million compared to CAD 4.14 million a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.17 CAD | +3.03% | +6.25% | -8.11% |
Mar. 15 | NeuPath Health Narrows Q4 Loss, Revenue Rises | MT |
Mar. 15 | NeuPath Health Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.11% | 6.99M | |
-14.44% | 84.68B | |
+14.84% | 81.12B | |
+11.62% | 29.59B | |
-8.82% | 16.73B | |
-1.39% | 16.36B | |
-31.58% | 11.77B | |
+1.82% | 11.72B | |
+30.92% | 11.71B | |
-0.47% | 11.66B |
- Stock Market
- Equities
- NPTH Stock
- News NeuPath Health Inc.
- NeuPath Health Inc. Reports Earnings Results for the Full Year Ended December 31, 2023